Skip to content

Drug interactions

Lomitapide + Ziprasidone

Severity: Minor

Lomitapide and Ziprasidone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ziprasidone is a weak CYP3A4 inhibitor at most, so the effect on lomitapide exposure is expected to be small. Lomitapide is highly sensitive to CYP3A4 inhibition, and its exposure may rise slightly, increasing the risk of liver enzyme elevation and gastrointestinal effects.

What this interaction means in plain words

Lomitapide and Ziprasidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lomitapide belongs to Cardiovascular; Ziprasidone belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition reducing lomitapide metabolism; the effect of ziprasidone is not well established.

What to do

Monitor liver enzymes according to lomitapide labeling and watch for gastrointestinal adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Ziprasidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomitapide with Ziprasidone?

MediHelp rates the interaction as minor. Lomitapide and Ziprasidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ziprasidone is a weak CYP3A4 inhibitor at most, so the effect on lomitapide exposure is expected to be small. Lomitapide is highly sensitive to CYP3A4 inhibition, and its exposure may rise slightly, increasing the risk of liver enzyme elevation and gastrointestinal effects.

How serious is the interaction between Lomitapide and Ziprasidone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes according to lomitapide labeling and watch for gastrointestinal adverse effects.

What other medicines interact with Ziprasidone?

MediHelp also lists interactions of Ziprasidone with, for example, Amiodarone, Amitriptyline, Arsenic trioxide. The full list is on the Ziprasidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in